BiomX (PHGE) Institutional Ownership $0.42 -0.32 (-43.30%) Closing price 07/11/2025 03:56 PM EasternExtended Trading$0.42 0.00 (-0.95%) As of 07/11/2025 06:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsBuy This Stock Institutional Ownership Changes (13F Filings) for BiomX (NYSEMKT:PHGE)CurrentInstitutional OwnershipPercentage40.57%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$3.79MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$3.50M Get PHGE Insider Trade Alerts Want to know when executives and insiders are buying or selling BiomX stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHGE Institutional Buying and Selling by Quarter BiomX Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025Allostery Investments LP940,629$523K0.8%+46.1%3.763% 5/16/2025Alyeska Investment Group L.P.1,590,738$884K0.0%+83.8%6.364% 5/16/2025ADAR1 Capital Management LLC299,598$166K0.0%N/A1.199% 5/15/2025Nantahala Capital Management LLC2,493,309$1.39M0.1%+44.1%9.975% 5/9/2025Warberg Asset Management LLC99,616$55K0.0%N/A0.399% 5/6/2025AIGH Capital Management LLC1,566,944$871K0.4%+81.1%6.269% 2/17/2025Alyeska Investment Group L.P.865,400$632K0.0%N/A4.761% 2/17/2025Allostery Investments LP643,833$470K0.5%N/A3.542% 2/14/2025Heights Capital Management Inc.258,492$189K0.1%-56.1%1.422% 2/14/2025Johnson & Johnson96,866$71K0.0%-49.6%0.533% Get the Latest News and Ratings for PHGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025JPMorgan Chase & Co.429,990$314K0.0%N/A2.366% 11/19/2024Barclays PLC25,000$26K0.0%-90.0%0.138% 11/15/2024Barclays PLC25,000$26K0.0%-90.0%0.140% 11/15/2024Ikarian Capital LLC893,000$911K0.1%N/A4.990% 11/14/2024Johnson & Johnson192,321$196K0.0%-90.0%1.075% 11/7/20248VC GP I LLC108,621$111K0.2%-90.0%0.607% 5/17/2024Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590% 5/10/2024Johnson & Johnson1,923,201$865K0.0%-9.9%3.483% 11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529% 5/5/2022Royce & Associates LP320,655$619K0.0%+200.5%1.077% 2/7/2022Royce & Associates LP106,696$171K0.0%-52.7%0.373% 11/12/2021Johnson & Johnson2,133,402$6.53M0.6%N/A7.568% 10/26/2021Taylor Wealth Management Partners40,098$91K0.0%-44.3%0.142% 8/17/2021Millennium Management LLC427,702$2.34M0.0%-5.9%1.758% 8/17/2021Bridgeway Capital Management LLC104,000$568K0.0%-15.4%0.427% 5/18/2021Millennium Management LLC454,377$3.24M0.0%-1.2%1.954% 5/18/2021Jane Street Group LLC25,365$181K0.0%N/A0.109% 5/13/2021Renaissance Technologies LLC36,200$258K0.0%N/A0.156% (Data available from 1/1/2016 forward) PHGE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHGE shares? During the previous two years, 12 institutional investors and hedge funds held shares of BiomX. The most heavily invested institutionals were Nantahala Capital Management LLC ($1.39M), Ikarian Capital LLC ($911K), Alyeska Investment Group L.P. ($884K), AIGH Capital Management LLC ($871K), Allostery Investments LP ($523K), JPMorgan Chase & Co. ($314K), and Heights Capital Management Inc. ($189K).Learn more on BiomX's institutional investors. What percentage of BiomX's stock is owned by institutional investors? 40.57% of BiomX's stock is owned by institutional investors. Learn more on PHGE's institutional investor holdings. Which institutional investors have been buying BiomX's stock? The following institutional investors have purchased BiomX's stock in the last 24 months: Ikarian Capital LLC ($11.71M), Alyeska Investment Group L.P. ($1.59M), Allostery Investments LP ($940.63K), Nantahala Capital Management LLC ($762.71K), AIGH Capital Management LLC ($701.54K), JPMorgan Chase & Co. ($429.99K), and ADAR1 Capital Management LLC ($299.60K). How much institutional buying is happening at BiomX? Institutional investors have bought a total of 5,717,824 shares in the last 24 months. This purchase volume represents approximately $3.79M in transactions. Which of BiomX's major shareholders have been selling company stock? The following institutional investors have sold BiomX stock in the last 24 months: Johnson & Johnson ($1.83M), 8VC GP I LLC ($977.57K), Barclays PLC ($450K), and Heights Capital Management Inc. ($330.54K). How much institutional selling is happening at BiomX? Institutional investors have sold a total of 3,584,440 shares in the last 24 months. This volume of shares sold represents approximately $3.50M in transactions. Related Companies INmune Bio Major Shareholders Celularity Major Shareholders ImmunoPrecise Antibodies Major Shareholders bluebird bio Major Shareholders vTv Therapeutics Major Shareholders Renovaro Major Shareholders Gain Therapeutics Major Shareholders Werewolf Therapeutics Major Shareholders Century Therapeutics Major Shareholders Atara Biotherapeutics Major Shareholders This page (NYSEMKT:PHGE) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiomX Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiomX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
